Samuel D Isaly's Net Worth

$0

Estimate Recalculated Jun 5, 2025 08:45PM EST

Who is Samuel D Isaly?

Samuel D Isaly does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., COMPLETE GENOMICS INC, INSULET CORP, Volcano Corp, AMARIN CORP PLC\UK, Relypsa Inc, ChemoCentryx, Inc., Mirati Therapeutics, Inc., GLAUKOS Corp, INTERCEPT PHARMACEUTICALS INC, Intellia Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., SUPERNUS PHARMACEUTICALS INC, PIERIS PHARMACEUTICALS, INC., ViewRay, Inc., CTI BIOPHARMA CORP, Aadi Bioscience, Inc., ProNAi Therapeutics Inc, Adaptimmune Therapeutics PLC, Pacira Pharmaceuticals, Inc., Loxo Oncology, Inc., Sientra, Inc., SELECTA BIOSCIENCES INC, Nabriva Therapeutics AG, Xtant Medical Holdings, Inc., Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Kala Pharmaceuticals, Inc., scPharmaceuticals Inc., SteadyMed Ltd., SYNLOGIC, INC., OTONOMY, INC., Arsanis, Inc., RESPONSE BIOMEDICAL CORP, AVANIR PHARMACEUTICALS, Roka BioScience, Inc., Audentes Therapeutics, Inc., Biodel Inc, AMBIT BIOSCIENCES CORP, Anthera Pharmaceuticals Inc, NxStage Medical, Inc., ACCELERON PHARMA INC, MEMORY PHARMACEUTICALS CORP, ORPHAN MEDICAL INC, Kun Run Biotechnology, Inc., ARYx Therapeutics, Inc., CRYOCOR INC, AEROGEN INC, ATHERSYS, INC / NEW, Corvus Pharmaceuticals, Inc., ORCHID BIOSCIENCES INC, GIVEN IMAGING LTD, LIFECELL CORP, and DOV PHARMACEUTICAL INC.

SEC CIK

Samuel D Isaly's CIK is 0001055949

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.9M
$17.00
—
2.9M
Oct 10
Form 3
—
0
—
—
0
No matching records found

COMPLETE GENOMICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.75%
-1.21M
$2.75
-$3,304,642.18
10.03M
Jul 11 - Jul 13
Form 3
—
0
—
—
0
No matching records found

INSULET CORP (PODD) Snapshot price: $214.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Volcano Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.37M
—
—
2.37M
Jun 20
Form 3
—
0
—
—
0
No matching records found

AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-28.03%
-233.70K
$14.43
-$3,372,992.10
600K
Scheduled
Sep 4
Form 4
-30.53%
-366.30K
$14.61
-$5,350,690.62
833.7K
Scheduled
Jul 27
Form 4
-33.96%
-617.10K
$12.91
-$7,968,427.17
1.2M
Jun 19
Form 4
-6.82%
-132.90K
$16.08
-$2,137,270.00
1.82M
Apr 29 - May 2
Form 4/A
-22.86%
-800.00K
$15.79
-$12,632,000.00
2.7M
Apr 20
Form 4
-27.78%
-750.00K
$16.67
-$12,500,000.00
1.95M
Apr 21
Form 4
-58.16%
-3.80M
$15.43
-$58,181,898.51
2.73M
Scheduled
Apr 18 - Apr 20
Form 4
-2.59%
-173.00K
$7.41
-$1,281,828.00
6.5M
Mar 24 - Mar 28
Form 4
-1.14%
-77.00K
$7.05
-$542,850.00
6.67M
Mar 21
Form 4
-3.23%
-225.00K
$7.35
-$1,654,750.00
6.75M
Mar 11 - Mar 15
Form 4
-1.06%
-75.00K
$7.66
-$573,980.00
6.97M
Mar 3 - Mar 7
Form 4
-3.36%
-245.00K
$7.69
-$1,884,400.00
7.05M
Feb 28 - Mar 2
Form 3
—
0
—
—
0
No matching records found